arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CHEMED CORP

CHE
$552.39 ▲ +3.44 (+0.63%) at close
Healthcare ·Services-Home Health Care Services ·USServices-Home Health Care Services
72 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

CHEMED CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $7.3B
Dividend Yield 0.11%
Revenue Growth 8.8%
Op. Margin 13.2%
ROIC 6.8%
FCF / Share $5.26
Trailing P/E 107.5x
Price / Book 8.8x
FCF Yield 1.0%
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Aug 7, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$673.25M
↑ +8.8%
Net Income Profit after all expenses
$67.70M
↑ +29.0%
Operating Margin Operating profit as % of sales
13.2%
↑ +3.0% 64th
FCF / Share Free cash flow per share
$5.26
↑ +1.2%
Long-Term Debt Long-term obligations
$140.00M
↑ +53.5%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
66
Returns
91
Financial Health
96
Cash Quality
74

Dividend History

Dividend / share · sourced from SEC filings
$2.20 Latest / share
+22.2% YoY
+9.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 72 quarters